Researchers from The University of Texas Medical Branch at Galveston, led by prostate cancer treatment pioneer Dr. Eric Walser, have shown that selectively destroying cancerous prostate tissue is as effective as complete ...
Mar 20, 2019
0
9
(HealthDay)—Most active interventions are more likely than no treatment to improve outcomes for women with either stress or urgency urinary incontinence (UI), according to a review published online March 19 in the Annals ...
Mar 19, 2019
0
1
Research suggests children can be reliably diagnosed with autism before the age of two. It also shows that many of the behavioural symptoms of autism are present before the age of one.
Nov 15, 2018
0
1
A relatively simple effort to provide counseling and connect injection-drug users with resources could prove powerful against the spread of HIV in a notoriously hard-to-reach population, new research suggests.
Aug 30, 2018
0
2
Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from the GLOBAL LEADERS trial ...
Aug 27, 2018
0
3
"I felt a sense of dissolving, disappearing completely." "My body and mind melted and merged with the universe." "I ceased to exist." These are excerpts of what I occasionally hear from the students who come to my yoga and ...
Aug 22, 2018
0
6
A study published in the current issue of Psychotherapy and Psychosomatics indicates that psychotherapy may improve psychological distress and help coping with multiple sclerosis. Psychosocial interventions are often used ...
Apr 19, 2018
0
17
(HealthDay)—Compliance with guideline-directed medical therapy (GDMT) is low, and remains higher in percutaneous coronary intervention (PCI) than in coronary artery bypass grafting (CABG), according to a review published ...
Feb 6, 2018
0
1
A new therapy aimed at helping young people suffering from schizophrenia to reconnect and engage with the world around them has had promising results, according to a new University of Sussex-led study.
Dec 11, 2017
0
9
(HealthDay)—Patients with a CYP2C19 loss-of-function allele have increased risk of major adverse cardiovascular events (MACE) with clopidogrel versus alternative antiplatelet therapy after percutaneous coronary intervention ...
Nov 3, 2017
0
0
